Oncology, cancer prevention, tumor biology, and immunotherapy relevant to longevity
316 articles
ASTER 70s trial compares treatment intensities for women 70+ with genomically high-risk breast cancer to optimize outcomes while minimizing toxicity.
Novel nanoparticle combines protein degrader with light therapy to reprogram cancer metabolism and eliminate breast tumors.
Researchers use advanced cell profiling to develop personalized immune treatments for thyroid cancer patients.
New research reveals how bone marrow cells produce taurine that feeds leukemia stem cells, offering potential therapeutic targets.
New research reveals how IGF2BP3 protein promotes triple-negative breast cancer spread by hijacking cellular recycling processes.
Phase 1/2 umbrella trial matches glioblastoma patients to targeted treatments based on tumor genetics, with temsirolimus showing significant benefit.
Engineered green tea compound nanoparticles activate cellular powerhouses to suppress tumor growth and improve immune response against melanoma.
Scientists develop LP-65, a single molecule targeting two cancer pathways simultaneously, showing enhanced anti-tumor effects in lab studies.
New study reveals how blocking ribosome production makes cancer cells vulnerable to ferroptosis, an iron-dependent cell death pathway.
New research reveals how a cancer-promoting protein reprograms cellular fat production to accelerate tumor progression.
New study reveals how cancer cells reprogram bone immune cells to fuel metastasis, offering potential therapeutic targets.
Researchers used advanced genetic analysis to find LGALS9 and SELL genes causally linked to aggressive brain tumors, revealing new treatment targets.
